Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Hiroe Tani

20 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: https://openalex.org/A5127390839

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 9 Clinical Trial 8 Addiction 6 Mechanism of Action 6 Receptor Pharmacology 6 Safety 5 Treatment-Resistant Depression 5 Anxiety 5 End-of-Life Distress 3 Review Article 3 Adverse Events 3 Animal Study 3

Journals

Research square 2 Journal of psychoactive drugs 2 CIIS Digital Commons (California Institute of Integral Studies) 2 Psychedelic medicine (New Rochelle, N.Y.) 1 ClinicalTrials.gov 1 Molecular psychiatry 1 Psychiatry and Clinical Neurosciences 1 Italian Botanist 1

Publication history

Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01 Psilocybin Recovery Intervention for Stopping Methamphetamine UseClinicalTrials.gov · 2026-08-11 Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.Molecular psychiatry · 2026-07-28 Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulationsPsychiatry and Clinical Neurosciences · 2026-06-01 Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers.Research square · 2026-02-12 The genus Psilocybe in ItalyItalian Botanist · 2025-12-22 Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders.Journal of psychoactive drugs · 2025-11-10 577. CLINICAL EVIDENCE AND APPLICATIONS OF PSYCHEDELICS FOR MENTAL ILLNESSESThe International Journal of Neuropsychopharmacology · 2025-07-31 Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-05-01 Psilocybin-assisted therapy and HIV-related shame.Scientific reports · 2024-08-02 Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.Naunyn-Schmiedeberg's archives of pharmacology · 2024-05-01 Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics.Journal of psychoactive drugs · 2024-01-01 The Psychedelic,-Dipropyltryptamine Prevents Seizures in a Mouse Model of Fragile X Syndrome via a Mechanism that Appears Independent of Serotonin and Sigma1 Receptors.ACS pharmacology & translational science · 2023-10-13 Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.Research square · 2023-07-07 Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry.Pharmacopsychiatry · 2022-07-01 Natural Psychoplastogens As Antidepressant Agents.Molecules (Basel, Switzerland) · 2020-03-05 1.13 Microdosing of Hallucinogens Among College Students: Frequency, Correlates, and ConsequencesJournal of the American Academy of Child & Adolescent Psychiatry · 2018-09-30 Psychedelic Research Resurrected: The Contributions of Stanislav GrofCIIS Digital Commons (California Institute of Integral Studies) · 2014-01-01 Stanislav Grof's Contributions to FDA Drug Development Research with PsychedelicsCIIS Digital Commons (California Institute of Integral Studies) · 2014-01-01 The Hallucinogenic Mushrooms of Mexico and Psilocybin: a BibliographyBotanical Museum leaflets Harvard University · 1962-09-07

Author directory